Study: High-dose losartan doesn't raise death risk in heart patients

04/11/2012 | PhysiciansBriefing.com

A Danish study of more than 6,000 heart failure patients found that those who take a high dose of losartan have the same risk of dying as those taking a high dose of candesartan. The risk of death, however, is higher among heart failure patients who take low- or medium-dose losartan. The findings appear in the Journal of the American Medical Association.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA